Brainstorm Cell Q4 EPS $(0.20) Beats $(0.37) Estimate

3/31/2026
Impact: 75
Healthcare

Brainstorm Cell (OTC:BCLI) reported a Q4 loss of $(0.20) per share, surpassing the analyst consensus estimate of $(0.37) by 45.95%. This represents a 60.78% improvement compared to losses of $(0.51) per share in the same period last year.

AI summary, not financial advice

Share: